We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Conagra Brands, Inc. (CAG - Free Report) has been fighting inflation over the last year. This Zacks Rank #5 (Strong Sell) recently guided below the Zacks Consensus for fiscal 2024.
Conagra is a food company with many iconic brands including Birds Eye, Duncan Hines, Healthy Choice, Marie Callender's, Reddi-wip, Slim Jim, as well as emerging brands Angie's Boomchickapop, Duke's, Earth Balance and Frontera.
A Beat in Fiscal Fourth Quarter 2024
On July 13, 2023, Conagra reported its fiscal fourth quarter and full year 2023 earnings and beat on the Zacks Consensus by $0.02. It reported $0.62 versus the Consensus of $0.60. It was the sixth earnings beat in a row.
Organic net sale rose 2.2% while adjusted operating margin decreased 39 basis points to 14.6%.
Conagra was able to institute inflation-driven pricing action in most of its segments even as volumes declined.
For the full fiscal year 2023, adjusted EPS increased 17.4% to $2.77, driven by an increase in adjusted operating profit. Free cash flow was also $633 million for the year.
Guided Full Year 2024 Below Consensus
Conagra provided fiscal 2024 guidance and it was below the Zacks Consensus. It gave a an earnings forecast of $2.70 to $2.75.
7 estimates were cut for 2024 as a result. The Zacks Consensus Estimate fell to $2.72 from $2.83 over the last 30 days to get within the guidance range.
This is an earnings decline of 1.8% year-over-year as it made $2.77 in fiscal 2023.
On inflation, Conagra expects cost of goods sold inflation to continue into fiscal 2024. The company's guidance anticipates net inflation (input cost inflation including the impacts of hedging and other sourcing benefits) to be roughly 3%.
Shares Sink in 2023
While the stock market rallies in 2023, Conagra shares have gone the opposite way, sinking 14.1% year-to-date.
Image Source: Zacks Investment Research
Conagra is cheap. It's trading at 12.2x forward earnings.
It's also shareholder friendly and is spending some of that free cash flow on dividends. It recently increased the annual dividend by 6% rate beginning on the payout on Aug 31, 2023. The dividend will jump to $1.40 from $1.32. That's a yield of 4.2%.
For those interested in food companies, you might want to keep Conagra on the watch list for positive revisions to those earnings estimates.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Bear of the Day: Conagra (CAG)
Conagra Brands, Inc. (CAG - Free Report) has been fighting inflation over the last year. This Zacks Rank #5 (Strong Sell) recently guided below the Zacks Consensus for fiscal 2024.
Conagra is a food company with many iconic brands including Birds Eye, Duncan Hines, Healthy Choice, Marie Callender's, Reddi-wip, Slim Jim, as well as emerging brands Angie's Boomchickapop, Duke's, Earth Balance and Frontera.
A Beat in Fiscal Fourth Quarter 2024
On July 13, 2023, Conagra reported its fiscal fourth quarter and full year 2023 earnings and beat on the Zacks Consensus by $0.02. It reported $0.62 versus the Consensus of $0.60. It was the sixth earnings beat in a row.
Organic net sale rose 2.2% while adjusted operating margin decreased 39 basis points to 14.6%.
Conagra was able to institute inflation-driven pricing action in most of its segments even as volumes declined.
For the full fiscal year 2023, adjusted EPS increased 17.4% to $2.77, driven by an increase in adjusted operating profit. Free cash flow was also $633 million for the year.
Guided Full Year 2024 Below Consensus
Conagra provided fiscal 2024 guidance and it was below the Zacks Consensus. It gave a an earnings forecast of $2.70 to $2.75.
7 estimates were cut for 2024 as a result. The Zacks Consensus Estimate fell to $2.72 from $2.83 over the last 30 days to get within the guidance range.
This is an earnings decline of 1.8% year-over-year as it made $2.77 in fiscal 2023.
On inflation, Conagra expects cost of goods sold inflation to continue into fiscal 2024. The company's guidance anticipates net inflation (input cost inflation including the impacts of hedging and other sourcing benefits) to be roughly 3%.
Shares Sink in 2023
While the stock market rallies in 2023, Conagra shares have gone the opposite way, sinking 14.1% year-to-date.
Image Source: Zacks Investment Research
Conagra is cheap. It's trading at 12.2x forward earnings.
It's also shareholder friendly and is spending some of that free cash flow on dividends. It recently increased the annual dividend by 6% rate beginning on the payout on Aug 31, 2023. The dividend will jump to $1.40 from $1.32. That's a yield of 4.2%.
For those interested in food companies, you might want to keep Conagra on the watch list for positive revisions to those earnings estimates.